Healthcare 02 (May 15 - Dec 25)

[winston]

This fascinating new technology could be the future of fighting cancer... by Dr. David Eifrig Jr.

In my book, The Living Cure, I wrote about groundbreaking cancer treatments that target the immune systems of patients…

Now, according to a recent study in Science Translational Medicine, we’re closer to tailoring treatments to individual patients.

Researchers at the Massachusetts Institute of Technology put a tiny robotic device into the patient’s body. The robot carries minute doses of up to 16 cancer-fighting drugs in separate tubes.

Once it attaches to the tumor, the device injects each of the drugs into parts of the cancer tissue. Doctors wait for the drugs to work, then remove the device along with a sample of the tumor.

Using the actual drugs inside a patient’s body mimics what a full dosage might do and how the body would react to a full dose. Doctors see which drug (or drugs) worked the best against your individual tumor cells.

Pinpointing which drug works for each person will greatly improve chemotherapy treatments.

Soon, patients will be able to receive the most effective full-dose drug right from the start, instead of enduring rounds and rounds of different drugs, hoping one finally kills the cancer cells (before the patient).

So far, dog and mouse testing and small test trials in humans with lymphoma have shown positive results. And with more human testing on the way, the future of cancer treatments keeps getting better and better.

Source: Retirement Millionaire

[winston]

Biotech-stock fund XBI touches a new 52-week high… up 31% in 2015.

[winston]

Investing in health care works… sector fund IYH climbs 20% over the past eight months.

[winston]

The ongoing boom in health care continues…

Our colleague Dr. David "Doc" Eifrig has written at length about how Obamacare and the aging "Baby Boomer" generation have created a huge opportunity in health care for investors.

Shares of health-insurance firms have skyrocketed since the launch of Obamacare in 2010. Last week, health-insurance firms Aetna (AET), Cigna (CI), and Humana (HUM) hit fresh all-time highs.

And it's not just insurance companies that are soaring… Pharmaceutical giant Eli Lilly (LLY) hit a new 13-year high this week… while the Health Care Select Sector SPDR Fund (XLV) and iShares U.S. Health Care Fund (IYH) are up more than 100% in the last three years.

Please Enable Images to See this

Doc has been all over this trend from the beginning. He has led his subscribers to triple-digit gains in medical-equipment giant Medtronic (MDT), drugstore chain CVS Health (CVS), and the Fidelity Select Medical Equipment and Systems Fund (FSMEX).

As Doc explained in the August 11 Digest Premium…

Back when I was in high school, health care spending accounted for less than 10% of gross domestic product (GDP). Today, it accounts for 18%… In 25 years, estimates project that number will rise to 24%.

One of the reasons for that increase is the aging Baby Boomer generation, which will lead to a 45% increase in the elderly population. That means more money will be spent on prescription drugs and on doctor visits.

Doc noted that elderly people take three to four times more prescription drugs than people younger than 50… and pointed out that 90% of seniors take at least one drug per month…

Add to that the average nursing home stay is nearly 2.3 years and costs more than $200,000. According to financial-services firm Fidelity, the average retiring couple will need $220,000 to pay for health care costs if both partners live into their 80s.

Drugstore chains will fill more prescriptions. Health care technology is a growing sector, and certain firms are ideally positioned. And of course, pharmacy benefit managers that help manage the prescription process are a great way to invest in this long-term trend.

Please Enable Images to See this All of this has led to a boom in health care-related job openings, as the industry tries to find new workers to keep up with demand…

In an article this week, Bloomberg noted that job listings in the health care sector have soared while hiring has failed to keep pace. That suggests that the U.S. workforce may not be able to meet the demand for health care workers. From the article…

The 910,000 listings in the health care industry almost doubled the 513,000 who were added to payrolls, meaning there were about 1.8 jobs available for every person who was hired. Across all private employers, that ratio tilted in the job seeker's favor for the first time ever in April.

Wages in the industry grew by 2.2% in the year through April after a 2.3% increase the prior month that was the strongest since the end of 2012, separate Labor Department
figures showed last week.

This trend is likely just getting started.

Source: Growth Stock Wire

[winston]

Warning: Top Healthcare Performers Now Overvalued

By Chris Worthington

Source: Wall Street Daily

http://www.thetradingreport.com/2015/06 ... vervalued/

[winston]

Invest With the “1 Percent”: Healthcare Stocks

Right now, only the cream of the crop will do

By Johnson Research Group

http://investorplace.com/2015/06/health ... X_9HtKqqko

[winston]

<Research Report>BNP Paribas Latest Ratings & TPs for Chinese Pharmaceuticals (Table)

BNP Paribas in a report listed out its investment ratings and target prices for Chinese pharmaceutical and hospital stocks.

Stock / Investment Rating / Target Price (HK$)
CSPC PHARMA (01093.HK) / Initial Buy / 9.3
FOSUN PHARMA (02196.HK) / Initial Buy / 38.5
SINO BIOPHARM (01177.HK) / Initial Buy / 11.2
PHOENIXHEALTH (01515.HK) / Initial Buy / 17.3

Source: AAStocks Financial News

[winston]

<Research Report>BNP Paribas Latest Ratings & TPs for Chinese Pharmaceuticals (Table)

BNP Paribas in a report listed out its investment ratings and target prices for Chinese pharmaceutical and hospital stocks.

Stock / Investment Rating / Target Price (HK$)
CSPC PHARMA (01093.HK) / Initial Buy / 9.3
FOSUN PHARMA (02196.HK) / Initial Buy / 38.5
SINO BIOPHARM (01177.HK) / Initial Buy / 11.2
PHOENIXHEALTH (01515.HK) / Initial Buy / 17.3

Source: AAStocks Financial News

[winston]

not vested

Vanguard Health Care (VGHCX)
Load Fee: None
Expenses: 0.34%, or $34 annually for every $10,000 invested
Minimum Initial Investment: $3,000


Health sector stocks have room to grow in 2015 and can also be a great defensive play. But you’ll need a low-cost, diversified fund like Vanguard Health Care (VGHCX) to get the job done.

Biotechnology stocks have fed much of the growth in the health sector but biotech is arguably overbought, which is a why minimal exposure to this hot sub-sector of health is best at this time.

Top holdings in the Vanguard Health Care portfolio include big pharmaceutical companies, such as Bristol-Myers Squibb (BMY) and Actavis (ACT), and managed care firms like UnitedHealth Group (UNH).

This diversified structure has resulted in short-term performance slightly below average for health sector funds but long-term performance for VGHCX is solidly ahead of the average health sector fund. And this is the kind of portfolio that might work best in the second half of 2015.


Source: Investor Place

[winston]

The Obese States Of America, And How To Profit From It

By Tyler Durden

The strategy for a Fat America is simple:
1. Long Health Care
2. Long Junk Food
3. Short Fitness
4. Short Healthy Food

http://www.thetradingreport.com/2015/06 ... t-from-it/